Sensorineural hearing loss in chronic suppurative otitis media with and without cholesteatoma  by de Azevedo, Alexandre Fernandes et al.
671
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 73 (5) SEPTEMBER/OCTOBER 2007
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Sensorineural hearing loss 
in chronic suppurative otitis 
media with and without 
cholesteatoma 
   Summary
Alexandre Fernandes de Azevedo 1, Daniele 
Cristine Gomes Pinto 2, Nicodemos José Alves de 
Souza 3, Dirceu Bartolomeu Greco 4, Denise Utsch 
Gonçalves 5
1 M.S. Otorhinolaryngology. Preceptor of Otorhinolaryngology at the Santa Casa de Misericórdia in Belo Horizonte.
2 Otorhinolaryngologist, Resident from the Otorhinolaryngology Department -Santa Casa de Misericórdia in Belo Horizonte.
3 M.S. Otorhinolaryngologist. Head of the Otorhinolaryngology Department - Santa Casa de Misericórdia in Belo Horizonte.
4 PhD. Full Professor of Internal Medicine - School of Medicine - Federal University of Minas Gerais (UFMG). MD. Advisor of the Postgraduate program in infectology 
and tropical medicine of the UFMG.  
 5 PhD. Adjunct Professor at the Department of Ophthalmology and Otorhinolaryngology and Hearing and Speech Therapy of the UFMG Medical School. Otorhinola-
ryngologist. Full advisor of the Postgraduate program in infectology and tropical medicine - UFMG. 
Federal University of Minas Gerais Medical School. Postgraduate program in Health Sciences: infectology and tropical medicine.
Send correspondence to: Denise Utsch Gonçalves Departamento de Oftalmologia, Otorrinolaringologia e Fonoaudiologia da Faculdade de Medicina da Universidade 
Federal de Minas Gerais - Av. Prof. Alfredo Balena 190 sala 3005 Belo Horizonte MG 30100-130.
Tel./Fax: (0xx31) 3248-9767 - E-mail: deniseg@medicina.ufmg.br
CNPq/Capes/Fapemig.
Paper submitted to the ABORL-CCF SGP (Management Publications System) on July 31th, 2006 and accepted for publication onFebruary 5th, 2007. cod. 3308.
Sensorineural hearing loss (SNHL) related to chronic 
suppurative otitis media (CSOM) was studied to clarify 
the involvement of cholesteatomas in this context. Aim: 
to evaluate SNHL related to CSOM and its association 
with cholesteatomas, disease duration and patients’ ages. 
Methods: Retrospective analysis of 115 patients with CSOM 
with and without cholesteatoma submitted to surgical 
treatment. Inclusion criteria were active unilateral disease, 
normal contralateral ear and age below 60 years. Results: 
The average age was 26.3 years, 58 males and 57 females. 
The duration of ear disease was, in average, 12.4 years. The 
average threshold of hearing was 40 dB in CSOM ear and 
22 dB in the normal contralateral ear (P=0.002). CSOM with 
cholesteatoma occurred in 78 of 115 cases. In the abnormal 
ear, SNHL was seen in 15 cases, being 6 cases of profound 
loss, that correlated with adjusted-age (P=0.003) and absence 
of cholesteatoma (P=0.01), but not with disease duration 
(P=0.458). Conclusion: SNHL occurred in 13% of the 
patients with CSOM, and was correlated with older age, but 
not with the presence of cholesteatoma or longer duration 
of ear disease.
Keywords: colesteatoma middle ear, otitis media suppurative, 
hearing loss.
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INTRODUCTION
Chronic otitis media may be considered a public 
health problem. In the United States, it is estimated that 
over two billion dollars are spent yearly to treat both acute 
and chronic ear infections1. In developing countries, the 
prevalence of middle ear infections reaches 72 cases per 
1,000 inhabitants and chronic otitis media is the main cau-
se of hearing loss in children2. In Brazil, epidemiological 
studies show an association between chronic otitis media 
and hearing loss in school age children3.
Now, considering suppurative chronic otitis media 
(SCOM), this may or may not be associated with the deve-
lopment of a cholesteatoma, and conductive hearing loss 
is the characteristic audiologic alteration4.
The association between chronic otitis media and 
sensorineural hearing loss (SNHL) has been broadly stu-
died and remains a controversial topic. Studies present 
a frequency that varies from no clinical significance5-9 to 
10%10. A variation in sample selection could justify this di-
fference. Some studies do not differentiate between SCOM 
with and without cholesteatoma5,11. Others assessed SCOM 
without considering the presence or absence of choleste-
atomas separately6,7,12. There is much controversy about 
the correlation between SNHL with the patient’s age and 
chronic otitis media duration time5-12. The socio-economic 
environment could also be a possible factor influencing 
SNHL evolution2,3.
The goal of the present investigation was to corre-
late SCOM associated with SNHL with cholesteatoma with 
patient’s age and disease duration.
METHODS
The present study was carried out through the 
analysis of charts from those patients submitted to otologic 
surgery because of SCOM with or without cholesteatomas. 
As for inclusion criterion we considered chronic unilateral 
otorrhea with a normal contralateral ear in patients with 
less than 60 years of age. As exclusion criteria, we consi-
dered the family history of congenital or acquired SNHL, 
history of noise exposure, head injury, prior ear surgery, 
or the possibility of a perilymphatic fistula. The socio-eco-
nomic statuses of the patients were controlled: having a 
private health insurance and having been submitted to ear 
surgery in a hospital that does not belong to the public 
health care system.
All patients were assessed, treated and followed up 
by the same professional, with vast experience in otology. 
In the month prior to the otologic surgery, audiometry 
exams were carried out in double by two independent 
professionals and who did not know about the patient’s 
clinical history or about the presence or absence of 
cholesteatoma. The exams were carried out in the same 
equipment and in a sound treated booth. In the audio-
metry analysis, the air-bone gap considered was of 10 dB 
to define a conductive hearing loss13. In order to define 
SNHL, we considered a 30dB hearing loss or above for 
the bone hearing threshold. This cutting point was used in 
order to rule out the inclusion of those cases that did not 
represent significant damage to the inner ear10. In order 
to increase the analysis specificity, we assessed the bone 
hearing loss alone in 4 KHz and the frequency averages 
of 0.5, 1 and 2 KHz10.
We assessed the correlation between SNHL with 
the following variables: age, ear disease duration and the 
presence or absence of cholesteatoma. The criterion to 
define the presence of cholesteatoma was the pathology 
description of the surgical specimen. In the case of the 
non-cholesteatomatous disease we considered the criteria 
of continuous otorrhea, resistant to antibiotic treatment for 
at least two months, associated to central eardrum perfo-
ration, and confirmation of cholesteatoma-free situation 
during surgery. 
The size of the calculated sample was of at least 
95 patients, considering the SNHL frequency in patients 
with SCOM as being of 10%10,14. The control used was the 
contralateral ear (paired) with normal otoscopy. The signi-
ficance level used was of 5% and the power was of 80%. 
The null hypothesis formulated was that the presence or 
absence of cholesteatomas in patients with SCOM did not 
interfere in the SNHL evolution. This research was classi-
fied as being of no risk for the patients (Cap. II, Art. 13) 
of resolution 196, of October 10, 1996, from the Ministry 
of Health, which rules clinical research in human beings 
in Brazil and was approved by the Ethics Committee in 
Research of the Institution, ETIC registration # 128/04.
RESULTS
The charts of 115 patients were assessed. Mean age 
was of 26.3 (SD=15.66), varying between 4 and 59 years, 
being 58 men and 57 women.
Average hearing threshold was of 40 dB in the ear 
with SCOM and 22 dB in the normal contralateral ear 
(P=0.002, CI=14.00-28.48).
Mean duration of the ear disease was of 12.4 
(SD=10.9), varying from 1 to 42 years. Table 1 shows the 
linear regression model to assess SNHL correlation with age 
and disease duration. We did not observe any correlation 
with duration (P=0.458), upholding the lack of statistical 
association when the analysis was stratified for the presen-
ce or absence of cholesteatoma. We observed a correlation 
with the adjusted age (P=0.003), in such a way as that for 
every 4 years of age increase, there was a reduction of 1 
dB in bone conduction, considering a 7% data dispersion 
and controlling the variable cholesteatoma. 
In the ear with SCOM, we observed normal air 
conduction audiometry in 25 (21.7%) cases, mild hearing 
loss in 43 (37.4%), moderate in 41 (31.7%) and severe or 
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profound in 6 (5.2%) cases. Considering the bone via, 
SNHL was seen in 15 (13%) cases, 8 of isolate loss in 4 
KHz and 7 with losses in 0.5, 1, 2, and also in 4 KHz.
In the contralateral ear with normal otoscopy (paired 
control), the air pathway was normal in 100 (86.9%) cases, 
mild in 13 (11.3%) and moderate in 2 (1.3%) cases.
Considering bone conduction, we observed 5 (4.3%) 
cases of mild SNHL isolated in 4 KHz.
Analyzing bone conduction hearing loss alone in 
4 KHz, there was no statistically significant  difference 
between the ears with SCOM and the normal contralateral 
ear (P=0.19; OR=2.04; CI=0.60-6.75). When we compared 
the alteration in the hearing threshold by bone conduction 
for the mean frequencies of 0.5, 1, 2 KHz in both groups, 
we did not see losses in the normal ear and in the ear with 
SCOM, moderate SNHL was seen in one case and severe 
to profound hearing loss in 6 cases. 
As to the presence of cholesteatoma, it was seen 
in 37 (32%) and it did not happen to 78 (68%) cases. As 
to the cholesteatoma interference analysis in SNHL de-
velopment, Table 2 shows the 15 cases observed in the 
group with SCOM, and the cholesteatoma was associated 
with bone conduction hearing threshold (p=0.01), in such 
a way that the SNHL was more intense in the group with 
SCOM without cholesteatomas.
DISCUSSION
In the present investigation, average hearing loss of 
40 Db was higher than the one observed in other series 
of cases, of which average varied from 19 to 33 Db in 
the frequencies of speech6,15. The longest duration of ear 
disease (12.4 years) up to the surgical intervention, with 
probable higher frequency of breakage in the ossicular 
chain could justify such difference11.
In the ear with SCOM, the frequency of SNHL was 
of 13% (15 cases). In a similar study, carried out with 
patients with a similar socio-economical status to those 
from the patients selected in the present study, SNHL was 
seen in 10% of the cases reviewed12. It is likely that SNHL 
associated with SCOM is higher in populations of lower 
socio-economic statuses2. Difficulties to access treatment 
with antibiotics, inadequate follow up of patients and 
worse hygiene and education situation could corroborate 
this hypothesis.
Disease duration does not correlate with SNHL 
(Table 1). In a study with similar methodology to ours, 
MacAndie & O’Reilly observed the same lack of correla-
tion, however they did not report on the mean duration 
of the ear disease in their patients9. This lack of correla-
tion observed in this study should be assessed with some 
questioning. Mean time of disease duration was of 12.4 
years. Therefore, there was a predominance of cases of 
long standing ear disease, in such a way that this cor-
relation between SNHL with a longer or shorter time of 
ear disease duration was limited, having seen that there 
were few cases with shorter times of disease duration. 
The correlation between SNHL and SCOM was previously 
shown by many authors5,11,12. Considering all the studies 
evaluated, including the one hereby presented, it is plau-
sible to speculate that the disease duration time variation, 
socio-economic status and cholesteatoma present could 
explain the different results found. The association obser-
ved between SNHL and adjusted age reinforces the idea 
that time-related variables could influence the tendency 
for SNHL in patients with SCOM.
SNHL was seen in SCOM with and without cho-
lesteatomas (Table 2). In many a study, SNHL associated 
with SCOM without cholesteatoma was disregarded or 
little considered5,6,7,9. It is worth mentioning that in these 
studies we considered cases of chronic otitis media that 
had their otorrhea interrupted with the antibiotic treat-
ment. The cases evaluated in the present investigation 
included chronic otorrhea that did not resolve with the 
antibiotic treatment. The cases assessed in the present 
investigation included chronic otorrhea that did not stop 
after antibiotic treatment. The assessment of SNHL in ears 
with chronic infection with persistent and not-persistent 
otorrhea must be different. Toxins produced by bacteria 
present in a chronic purulent secretion in the middle ear 
Table 1. Linear regression model for patient’s age and ear disease 
duration influencing the evolution towards sensorineural hearing 
loss in 115 cases of suppurative chronic otitis media.
Model Coefficient
Standard 
Deviation
P value
Constant 9.73 2.54 <0.001
Disease du-
ration
0.10 0.13 0.458
Age 0.25 0.08 0.003
Table 2. Sensorineural hearing loss in 115 patients with unilateral 
suppurative chronic otitis media (37 with and 78 without cholesteato-
ma) and normal contralateral ear (paired control).
Bone con-
duction 
threshold
Suppurative chronic otitis media Contralateral 
With cho-
lesteatoma
N=37(%)
Without
cholesteatoma
N=78(%)
Total N=115(%)
> or = 30 
dB in 0.5, 
1, 2 KHz 
(average)
1(2,7) 6(7,7) 7(6,0) 0
> or = 30 
dB only in 
4 KHz
6(16,2) 2(2,5) 8(6,9) 5(4,3)
P value 0,58 0,01 0,08 1,00
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would cause more damage to the inner ear when compa-
red to non-persistent otorrhea and the toxins production is 
not continuous16,17. Paparella et al. showed, in an elegant 
experimental study this association between SNHL and 
SCOM18. They emphasized the deleterious consequences 
of chronic otorrhea for the inner ear. The cochlear damage 
has been attributed to the passage of toxins through the 
round window, causing damage to the hair cells, especially 
in the cochlear base16,17. Persistent inflammation associated 
with chronic otorrhea would increase the round window’s 
permeability to bacterial toxins17,18. SNHL occurring in 
non-cholesteatomatous SCOM must be considered in the 
analysis of patients in whom surgical treatment is delayed 
for whatever reason. The explanation for a higher SNHL 
intensity in cases without cholesteatoma observed in the 
present investigation is merely speculative: the presence 
of an epithelial tumor would cause middle ear mucosal 
thickening, making it difficult for the bacteria to access 
the inner ear. 
CONCLUSION
According to the present study, SCOM with or 
without cholesteatoma may evolve towards SNHL, which 
was observed in 13% of the cases and is correlated with an 
age increase, but not with the presence of cholesteatoma 
or with a longer duration of otologic disease. 
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